• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原始抗原性失误:免疫记忆的负面影响及对 COVID-19 的启示。

Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.

机构信息

Center for Infectious Disease, Division of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, Houston, Texas, USA

Center for Infectious Disease, Division of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, Houston, Texas, USA.

出版信息

mSphere. 2021 Mar 10;6(2):e00056-21. doi: 10.1128/mSphere.00056-21.

DOI:10.1128/mSphere.00056-21
PMID:33692194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546681/
Abstract

The concept of original antigenic sin (OAS) was put forth many years ago to explain how humoral memory responses generated against one set of antigens can affect the nature of antibody responses elicited to challenge infections or vaccinations containing a similar but not identical array of antigens. Here, we highlight the link between OAS and the germinal center reaction (GCR), a process unique to activated B cells undergoing somatic hypermutation and class switch recombination. It is the powerful response of activated memory B cells and the accompanying GCR that establish the foundations of OAS. We apply these concepts to the current COVID-19 pandemic and put forth several possible scenarios whereby OAS may result in either beneficial or harmful outcomes depending, hypothetically, on prior exposure to antigens shared between SARS-CoV-2 and seasonal human coronaviruses (hCoVs) that include betacoronaviruses (e.g., HCoV-OC43 and HCoV-HKU1) and alphacoronaviruses (e.g., HCoV-NL63 and HCoV-HKU1) (E. M. Anderson, E. C. Goodwin, A. Verma, C. P. Arevalo, et al., medRxiv, 2020, https://doi.org/10.1101/2020.11.06.20227215; S. M. Kissler, C. Tedijanto, E. Goldstein, Y. H. Grad, and M. Lipsitch, Science 368:860-868, 2020, https://doi.org/10.1126/science.abb5793).

摘要

抗原原始感染(OAS)的概念多年前被提出,用以解释针对一组抗原产生的体液记忆应答如何影响针对具有相似但不完全相同抗原谱的挑战感染或疫苗接种所引起的抗体应答的性质。在这里,我们强调了 OAS 与生发中心反应(GCR)之间的联系,这是一种独特的过程,仅发生在经历体细胞超突变和类别转换重组的活化 B 细胞中。正是活化记忆 B 细胞的强大应答以及伴随的 GCR 为 OAS 奠定了基础。我们将这些概念应用于当前的 COVID-19 大流行,并提出了几种可能的情况,根据假设,OAS 可能导致有益或有害的结果,这取决于 SARS-CoV-2 与季节性人类冠状病毒(hCoVs)之间共同抗原的先前暴露,包括β冠状病毒(例如,HCoV-OC43 和 HCoV-HKU1)和α冠状病毒(例如,HCoV-NL63 和 HCoV-HKU1)(E. M. Anderson, E. C. Goodwin, A. Verma, C. P. Arevalo, 等,medRxiv,2020,https://doi.org/10.1101/2020.11.06.20227215;S. M. Kissler, C. Tedijanto, E. Goldstein, Y. H. Grad, 和 M. Lipsitch,Science 368:860-868, 2020,https://doi.org/10.1126/science.abb5793)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4f/8546681/ce9dc9d23228/msphere.00056-21-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4f/8546681/ce9dc9d23228/msphere.00056-21-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4f/8546681/ce9dc9d23228/msphere.00056-21-f0001.jpg

相似文献

1
Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.原始抗原性失误:免疫记忆的负面影响及对 COVID-19 的启示。
mSphere. 2021 Mar 10;6(2):e00056-21. doi: 10.1128/mSphere.00056-21.
2
Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities.COVID-19 患者不同疾病严重程度下对季节性人类冠状病毒的交叉反应性体液免疫应答。
Int J Infect Dis. 2021 Oct;111:68-75. doi: 10.1016/j.ijid.2021.08.026. Epub 2021 Aug 15.
3
T Cell Memory: Understanding COVID-19.T 细胞记忆:了解 COVID-19。
Immunity. 2021 Jan 12;54(1):14-18. doi: 10.1016/j.immuni.2020.12.009. Epub 2020 Dec 19.
4
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1).COVID-19 病情较轻与针对季节性人类冠状病毒 OC43 和 HKU1(HCoV OC43、HCoV HKU1)的抗体水平升高有关。
Int J Infect Dis. 2021 Apr;105:304-306. doi: 10.1016/j.ijid.2021.02.085. Epub 2021 Feb 23.
5
Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost.在生发中心增加 B 细胞选择的严格性可以解释低剂量初免或延迟加强的 COVID-19 疫苗的高效性。
Front Immunol. 2021 Nov 30;12:776933. doi: 10.3389/fimmu.2021.776933. eCollection 2021.
6
A speed limit on serial strain replacement from original antigenic sin.抗原初感染记忆中序列应变替换的速度限制。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2400202121. doi: 10.1073/pnas.2400202121. Epub 2024 Jun 10.
7
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection.滤泡辅助 T 细胞在 SARS-CoV-2 感染中的免疫发病机制。
Front Immunol. 2021 Sep 16;12:731100. doi: 10.3389/fimmu.2021.731100. eCollection 2021.
8
[Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].[针对严重急性呼吸综合征冠状病毒2的免疫记忆:针对初次感染的抗体和针对未来感染的记忆B细胞]
Med Sci (Paris). 2021 Aug-Sep;37(8-9):722-725. doi: 10.1051/medsci/2021122. Epub 2021 Aug 4.
9
A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection.关于新型冠状病毒2型感染重症中原始抗原罪的一种新假说。
Monoclon Antib Immunodiagn Immunother. 2020 Aug;39(4):107-111. doi: 10.1089/mab.2020.0029. Epub 2020 Aug 10.
10
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.在小鼠模型中观察到针对贝塔冠状病毒刺突蛋白的原始抗原性感染反应,但在儿童感染 SARS-CoV-2 后并不明显。
PLoS One. 2021 Aug 27;16(8):e0256482. doi: 10.1371/journal.pone.0256482. eCollection 2021.

引用本文的文献

1
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections.决定反复感染黄病毒属病毒后免疫印记结果的因素。
Front Immunol. 2025 Jul 16;16:1560851. doi: 10.3389/fimmu.2025.1560851. eCollection 2025.
2
Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2.接种 SARS-CoV-2 疫苗个体中的受体结合域特异性 B 细胞记忆反应。
Vaccines (Basel). 2024 Dec 12;12(12):1396. doi: 10.3390/vaccines12121396.
3
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells.

本文引用的文献

1
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.季节性人类冠状病毒抗体在感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后会增强,但与保护作用无关。
Cell. 2021 Apr 1;184(7):1858-1864.e10. doi: 10.1016/j.cell.2021.02.010. Epub 2021 Feb 9.
2
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.人类对 SARS-CoV-2 的预先存在和新产生的体液免疫。
Science. 2020 Dec 11;370(6522):1339-1343. doi: 10.1126/science.abe1107. Epub 2020 Nov 6.
3
A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
非交叉反应表位主导 COVID-19 疫苗接种的体液免疫反应 - 血浆抗体、浆母细胞和记忆 B 细胞的动力学。
Front Immunol. 2024 May 14;15:1382911. doi: 10.3389/fimmu.2024.1382911. eCollection 2024.
4
The "original antigenic sin" and its relevance for SARS-CoV-2 (COVID-19) vaccination.“原始抗原罪”及其与严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新型冠状病毒肺炎)疫苗接种的相关性。
Clin Immunol Commun. 2021 Dec;1:13-16. doi: 10.1016/j.clicom.2021.10.001. Epub 2021 Oct 8.
5
Waning immunity and IgG4 responses following bivalent mRNA boosting.二价 mRNA 加强免疫后免疫应答减弱和 IgG4 反应下降。
Sci Adv. 2024 Feb 23;10(8):eadj9945. doi: 10.1126/sciadv.adj9945.
6
Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.利用预先存在的流感病毒特异性免疫力可增强针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体反应。
J Virol. 2024 Feb 20;98(2):e0157123. doi: 10.1128/jvi.01571-23. Epub 2024 Jan 11.
7
Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain.基于SARS-CoV-2毒株的疫苗序贯接种可有效诱导针对此前未接触过的奥密克戎毒株的强效免疫反应。
Pathogens. 2023 Apr 28;12(5):655. doi: 10.3390/pathogens12050655.
8
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies.基于BIV1-CovIran研究,寻求保护是共享中和抗体反应以抵御所有新出现的变异株的关键。
Heliyon. 2023 Mar;9(3):e14108. doi: 10.1016/j.heliyon.2023.e14108. Epub 2023 Feb 26.
9
Weighted gene co-expression network-based identification of genetic effect of mRNA vaccination and previous infection on SARS-CoV-2 infection.基于加权基因共表达网络的 mRNA 疫苗接种和既往感染对 SARS-CoV-2 感染的遗传效应鉴定。
Cell Immunol. 2023 Mar;385:104689. doi: 10.1016/j.cellimm.2023.104689. Epub 2023 Feb 10.
10
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview.冠状病毒在人体内引发的直接、间接及感染后损伤:综述
Virusdisease. 2022 Dec;33(4):429-444. doi: 10.1007/s13337-022-00793-9. Epub 2022 Oct 25.
对 SARS-CoV-2 潜在抗体依赖性增强作用的看法。
Nature. 2020 Aug;584(7821):353-363. doi: 10.1038/s41586-020-2538-8. Epub 2020 Jul 13.
4
Human neutralizing antibodies elicited by SARS-CoV-2 infection.SARS-CoV-2 感染诱导的人体中和抗体。
Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26.
5
Germinal Center Reaction.生发中心反应。
Adv Exp Med Biol. 2020;1254:47-53. doi: 10.1007/978-981-15-3532-1_4.
6
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学,直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
7
It is too soon to attribute ADE to COVID-19.将异常药物反应归因于新冠病毒还为时过早。
Microbes Infect. 2020 May-Jun;22(4-5):158. doi: 10.1016/j.micinf.2020.03.005. Epub 2020 Apr 5.
8
Is COVID-19 receiving ADE from other coronaviruses?新冠病毒是否会从其他冠状病毒中获得增强效应?
Microbes Infect. 2020 Mar;22(2):72-73. doi: 10.1016/j.micinf.2020.02.006. Epub 2020 Feb 22.
9
Original Antigenic Sin: How Original? How Sinful?原始抗原性错误:有多原始?有多罪恶?
Cold Spring Harb Perspect Med. 2021 May 3;11(5):a038786. doi: 10.1101/cshperspect.a038786.
10
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.原始抗原性错误:初次接触如何塑造终身抗流感病毒免疫反应。
J Immunol. 2019 Jan 15;202(2):335-340. doi: 10.4049/jimmunol.1801149.